Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study aims to define a safe prophylactic intravenous TXA dose with an advantage over others in reducing total blood loss volume at secondary uncomplicated LSCS.
Epistemonikos ID: f59784fe4fe53736e62f870eb4643c5f961b6763
First added on: May 12, 2024